Onconova Therapeutics Buy Hold or Sell Recommendation
| ONTXDelisted Stock | USD 1.02 0.04 3.77% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Onconova Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Onconova Therapeutics given historical horizon and risk tolerance towards Onconova Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Onconova Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. In addition, we conduct extensive research on individual companies such as Onconova and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Onconova Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Onconova |
Execute Onconova Therapeutics Buy or Sell Advice
The Onconova recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Onconova Therapeutics. Macroaxis does not own or have any residual interests in Onconova Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Onconova Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Onconova Therapeutics Trading Alerts and Improvement Suggestions
| Onconova Therapeutics is now traded under the symbol TRAW. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Onconova Therapeutics is not yet fully synchronised with the market data | |
| Onconova Therapeutics has some characteristics of a very speculative penny stock | |
| Onconova Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 226 B. Net Loss for the year was (18.95 T) with profit before overhead, payroll, taxes, and interest of 226 K. | |
| Onconova Therapeutics currently holds about 46.53 M in cash with (17.93 T) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Onconova Therapeutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Onconova analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Onconova analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Onconova Therapeutics Returns Distribution Density
The distribution of Onconova Therapeutics' historical returns is an attempt to chart the uncertainty of Onconova Therapeutics' future price movements. The chart of the probability distribution of Onconova Therapeutics daily returns describes the distribution of returns around its average expected value. We use Onconova Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Onconova Therapeutics returns is essential to provide solid investment advice for Onconova Therapeutics.
| Mean Return | 0.85 | Value At Risk | -8.33 | Potential Upside | 7.69 | Standard Deviation | 8.91 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Onconova Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 8727 shares by Steven Fruchtman of Onconova Therapeutics at 0.9 subject to Rule 16b-3 [view details]
Onconova Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Onconova . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Onconova Therapeutics Buy or Sell Advice
When is the right time to buy or sell Onconova Therapeutics? Buying financial instruments such as Onconova Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Onconova Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Israel Wall Street Thematic Idea Now
Israel Wall Street
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 71 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Onconova Stock
If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |